FAM192BP

Across TCGA pan-cancer cohorts, FAM192BP RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated FAM192BP data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher FAM192BP RNA is associated with better overall survival. In most high-consensus cancer types, elevated FAM192BP expression acts as an unfavorable survival marker, although some lineages such as BLCA and READ show a favorable association.

BLCA, READ, and LIHC are the cancer types where FAM192BP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	III,IV	0.489	0.273	.002	90	view →
READ	DFS	Tertile	II,III,IV	0.969	0.605	.001	51	view →
LIHC	OS	Median	II,III,IV	0.554	0.816	<.001	43	view →
LUSC	DFS	Median	III,IV	0.469	0.910	.021	19	view →
KIRP	OS	Median	All	0.854	0.949	.007	12	view →
LAML	DFS	Tertile	All	0.592	0.294	.029	8	view →
ACC	DFS	Median	All	0.322	0.703	.014	8	view →
MESO	DFS	Median	III,IV	0.294	0.440	.021	7	view →
KICH	OS	Median	III,IV	0.715	0.980	.008	7	view →
COAD	DFS	Tertile	IV	0.673	0.243	.018	6	view →
PCPG	DFS	Tertile	All	0.496	0.915	.009	6	view →
OV	DFS	Tertile	IV	0.504	0.347	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

FAM192BP–BLCA (OS)

Open the BLCA breakdown →